Bimatoprost implant for treating open angle glaucoma or ocular hypertension when topical treatments are unsuitable [ID6180]

  • Discontinued
  • GID-TA11146
Please note that following on from advice received from the company this appraisal has been scheduled to align with latest regulatory expectations. Therefore, the appraisal will begin in Q1 2024 when we will write to you about how you can get involved.